Form 4: Biohaven CEO Vlad Coric Acquires 121,951 Shares in Public Offering

Biohaven CEO Vlad Coric reports the acquisition of 121,951 common shares through a public offering at $41 per share, along with holdings in 401(k) and family trusts.

Summary

• On April 22, 2024, Vlad Coric, the CEO of Biohaven Ltd., acquired 121,951 common shares of Biohaven at a price of $41 per share.
• The acquisition was part of an underwritten public offering.
• Following the transaction, Coric directly owns 1,788,417 common shares.
• Coric also has indirect ownership through a 401(k) plan (109,565 shares), The Vlad Coric Family Trust (840,890 shares), and The Vladimir Coric Marital Trust (407,213 shares).
• Coric disclaims beneficial ownership of the shares held in the family and marital trusts, where his spouse serves as trustee.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by the CEO. The purchase itself could be seen as slightly positive, indicating confidence, but the document is primarily informational.

Positives

• The CEO's purchase of a significant number of shares in a public offering could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider trading activities, which are common in publicly traded companies. Investors often monitor these filings to gauge management's sentiment about the company's stock.

Stakeholder Impact

• The CEO's stock purchase could positively influence shareholder sentiment.

Key Dates